ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)

ClinicalTrials.gov ID: NCT01331005

Public ClinicalTrials.gov record NCT01331005. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema

Study identification

NCT ID
NCT01331005
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Jaeb Center for Health Research
Other
Enrollment
125 participants

Conditions and interventions

Interventions

  • Nepafenac Vehicle Other
  • nepafenac 0.1% drops Drug

Other · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2011
Primary completion
Nov 30, 2013
Completion
Nov 30, 2013
Last update posted
Mar 9, 2025

2011 – 2013

United States locations

U.S. sites
32
U.S. states
21
U.S. cities
32
Facility City State ZIP Site status
Loma Linda University Health Care, Dept. of Ophthalmology Loma Linda California 92354
Southern California Desert Retina Consultants, MC Palm Springs California 92262
California Retina Consultants Santa Barbara California 93103
Bay Area Retina Associates Walnut Creek California 94598
Retinal Consultants of Southern California Medical Group, Inc. Westlake Village California 91361
Retina Consultants of Southwest Florida Fort Myers Florida 33912
Central Florida Retina Institute Lakeland Florida 33805
Southeast Retina Center, P.C. Augusta Georgia 30909
Retina Associates of Hawaii, Inc. Honolulu Hawaii 96813
Raj K. Maturi, M.D., P.C. Indianapolis Indiana 46290
American Eye Institute New Albany Indiana 47150
Wolfe Eye Clinic West Des Moines Iowa 50266
Retina and Vitreous Associates of Kentucky Lexington Kentucky 40509-1802
Paducah Retinal Center Paducah Kentucky 42001
Elman Retina Group, P.A. Baltimore Maryland 21237
Joslin Diabetes Center Boston Massachusetts 02215
Henry Ford Health System, Dept of Ophthalmology and Eye Care Services Detroit Michigan 48202
Vitreo-Retinal Associates Grand Rapids Michigan 49525
University of Minnesota Minneapolis Minnesota 55455
Eyesight Ophthalmic Services, PA Portsmouth New Hampshire 03801
Eye Care for the Adirondacks Plattsburgh New York 12901
Retina-Vitreous Surgeons of Central New York, PC Syracuse New York 13224
Charlotte Eye Ear Nose and Throat Assoc, PA Charlotte North Carolina 28210
Retina Associates of Cleveland, Inc. Beachwood Ohio 44122
Retina Northwest, PC Portland Oregon 97210
Family Eye Group Lancaster Pennsylvania 17601-2644
Southeastern Retina Associates, PC Kingsport Tennessee 37660
Southeastern Retina Associates, P.C. Knoxville Tennessee 37909
Texas Retina Associates Lubbock Texas 79424
Retinal Consultants of San Antonio San Antonio Texas 78240
University of Washington Medical Center Seattle Washington 98195
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01331005, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 9, 2025 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01331005 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →